Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
The Fake 96,000-Patient Database That Sank Hydroxychloroquine... And Medicine's Growing Black-Box
Pfizer inks $2.3 B CAR-T deal with China's Starna Therapeutics
Pfizer (NYSE:PFE) Stock Falls 1.5% - What's Next?
Deals/M&As: Pfizer, Starna ink $2.6B autoimmune deal and more
Pfizer leaps into 'in vivo' CAR-T with latest China deal
3 ETFs For Pfizer After Its Autoimmune Disease Deal
4 Dividend Stocks Yielding Over 6% That Fit a Roth IRA
3 High-Yield Dividend Stocks Down Nearly 30% or More in 5 Years
Pfizer Licenses Autoimmune Disease Programs From Starna In Deal Worth Upto $2.63 Bln
Pfizer signs licensing deal with Starna for experimental CAR-T programs
Pfizer (NYSE:PFE) Share Price Crosses Below Fifty Day Moving Average - Time to Sell?
Glenmark Pharma shares rise over 2% as unit files US application for experimental solid-tumour drug
What Is Pfizer (PFE) Asking Of Its $10 Billion Metsera Bet?
Pfizer (NYSE:PFE) Stock Falls 1.6% - Here's What Happened
Wall Street Forgot These 3 Dividend Stocks - Now They Pay Over 5%
5 Safe High-Yield Dividend Stocks Boomers Should Buy Before Year-End
Conagra Cut Its Dividend 50%. The Stock Market Was Warning Investors
5 "Forever Income" Dividend Stocks Yielding 5% and More for Boomers
5 Dividend Stocks Yielding Over 5% to Hide in Your Roth IRA
Dividend Stocks To Keep An Eye On - November 17th - Daily Political
Pfizer CEO Sees Growth Beyond Patent Cliff, Highlights Monthly Obesity Drug Ambitions
5 Ultra-High-Yield Dividend Stocks Retirees Should Buy Before December
Promising Dividend Stocks To Follow Today - November 16th - Stock Observer
Is Pfizer (PFE) Undervalued On Its $1.5b Berobenatide Funding Deal?
Glenmark launches generic Inlyta tablets for kidney cancer treatment in US
Pfizer Inc. $PFE Shares Sold by Russell Investments Group Ltd. - Daily Political
Pfizer (NYSE:PFE) Stock Lifted to "Buy" by Wall Street Zen - Markets Daily
$12,300 a Month in Dividends and Not One Bond: Is This Portfolio Too Good to Be True?
How Much Does a 65-Year-Old Need Invested in Dividend Stocks to Collect $2,000 a Month?
How Many Shares of Pfizer, Merck or Bristol Myers Squibb Pay $1,000 a Month in Dividends?
Wall Street Zen Upgrades Pfizer (NYSE:PFE) to Buy
Pfizer (PFE) Stock Looks Above Fair Value As Shares Rebound
Pfizer (PFE) Secures $1.5 Billion For Berobenatide Development
Pfizer Just Raised Its 2026 Revenue Forecast by $1.5 Billion. Is the High-Yield Stock a Buy Right Now?
Pharmaceutical Stocks Worth Watching - November 13th - Markets Daily
Health Matters: Pfizer to halt sales of certain hormone therapy
Pfizer Is Up 15.78% This Year, but $1,000 From Five Years Ago Is Still Worth Just $704 With Dividends Reinvested
A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer
Decoding treatment non-response in spondyloarthritis
Pfizer brings Blackstone in to finance its $1.5 billion obesity drug gamble
Blackstone bets $1.5B on Pfizer's obesity drug
Pfizer pact with Blackstone brings as much as $1.5B for GLP-1 effort
Pfizer bero hero Blackstone funds GLP-1 run to $1.5B
Blackstone Is Paying Up to $1.5 Billion for Pfizer's Answer to Wegovy
Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewer Treatment-Related Adverse Events and No Viral Rebounds Versus PAXLOVID®
Eli Lilly Shares Rise 2.8% After China Approves Orforglipron Weight-Loss Pill
Blackstone puts up $1.5 billion for Pfizer obesity drug studies
Pfizer, Blackstone Strike Up To $1.5 Bln Co-Funding Deal To Develop Obesity Drug Berobenatide
Why Is Pfizer (PFE) Facing Fresh Global mRNA Patent Lawsuits?
Pfizer Signs $1.5 Billion Deal With Blackstone to Fund Weight-Loss-Drug Development | Morningstar
Medicus Pharma Q3 Earnings Call Highlights - Stock Observer
Americans Fill Prescriptions Every Month, and $90,000 Across These 3 Drugmakers Pays $3,650 a Year
Promising Pharmaceutical Stocks To Consider - November 9th - Daily Political
Debunked: Old, discredited claims revived saying that Pfizer vaccines cause infertility
33,543 Pfizer Inc. $PFE Shares Sold by Illinois Municipal Retirement Fund - Markets Daily
3 Magnificent Dividend Stocks Yielding 4% or More to Buy in November
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Susie Wiles 'Pay-For-Play' Scandal Goes Nuclear With New Pfizer Accusations; White House Responds
Pfizer's comeback gets a new finance chief
Some Investors May Be Willing To Look Past Pfizer's (NYSE:PFE) Soft Earnings - Simply Wall St News
Medicus Pharma Ltd (MDCX) Q3 2026 Earnings Call Highlights: Pfizer ADC License, SkinJet SPAC ...
Expo Rx for success with foreign pharma biz
Trogenix appoints industry veterans John Young as Chair and Josh Murray as Non-Executive Director to support global strategy, commercial foundation and patient access | Valuespectrum.com
Pfizer (PFE) Stock Looks Overvalued On Its 29% One Year Gain
Medicus Pharma Q3 Earnings Call Highlights - Markets Daily
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
Pfizer raises profit forecasts as Eliquis, cancer drugs drive third-quarter results
Pfizer Inc. (NYSE:PFE) Stock Now Rated "Hold" by Sell-Side Analysts
Pfizer (PFE) Lifts Guidance Following Pipeline Wins While Fair Value Looks Near Reach
Pfizer Inc. $PFE Holdings Increased by Pictet Asset Management Holding SA - Daily Political
Democratic attorney-general wins could reshape US lawsuits on abortion, immigration and more
Pfizer And 2 More AI Healthcare Stocks To Watch
Dividend Stocks To Keep An Eye On - November 7th - Stock Observer
Pfizer (NYSE:PFE) Stock Rating Cut to "Hold" at DZ Bank - Stock Observer
Pfizer (NYSE:PFE) Price Target Raised to $30.00 - Stock Observer
Xeris Biopharma (XERS) Adds Menassie M. Taddese To Its Board
Pfizer (PFE) Plans $650 Million Connecticut Center For Clinical Drug Production
Pfizer (NYSE:PFE) Stock Gets Price Target Bump from Freedom Broker
Pfizer (PFE) Maps Out $650 Million Connecticut Center For Global Clinical Trials
Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?
Moderna Climbs 5% as Surprise Profit and Raised Outlook Beat Forecasts; Pfizer Dips, BioNTech Edges Higher
CFOs On the Move: Week ending Nov. 6
Global Hemophilia B Gene Therapy Market Report 2026 | Capitalize on 29.8% CAGR as Pfizer, CSL Behring, Bayer, and REGENXBIO Accelerate AAV Innovation
Pfizer (NYSE:PFE) Stock Falls 1.7% After Analyst Downgrade - Daily Political
5 High-Yield Dividend Stocks That Could Hold Up When the Market Falls
Promising Dividend Stocks To Add to Your Watchlist - November 3rd - Daily Political
Pfizer (NYSE:PFE) Stock Rating Lowered by DZ Bank
Buy, Sell, or Hold? Friday's Top Upgrades and Downgrades: Becton Dickinson, BJ's Wholesale Club, Cogent Communications, Fervo Energy, JinkoSolar, Molson-Coors, Pfizer, SiTime, Steven Madden, and More
PFIZER News
Will Jensen Huang Return as Nvidia CEO? What It Means for NVDA Stock
Nvidia Stock Forecast After Jensen Huang Resigns: Buy the Dip or Wait?
Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?
Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks
Latest news
Show more
AMD Stock Rises 5.3% as Nvidia’s $130 Billion Outlook Signals Strong AI Demand
Bank of America Stock Falls to $48.91 After Berkshire Cuts Stake Again
Bitcoin Slides Toward $62,000 as ETF Outflows Mount and Fed Rate Hike Bets Persist
Anthropic IPO Prices at $83 and Raises $81.3 Billion: How High Can ANT Stock Open?
Gold Price Today : Spot Gold Rebounds to $3,755 as Fed Rate Hike Risk Persists
Alibaba Earnings Today: Can AI Cloud Growth Offset China’s Consumer Slowdown?
